Related Experiment Video
Updated: May 22, 2025

06:00
Author Spotlight: Development of a Smartphone-Enhanced Paper-Based Device for Rapid Dengue NS1 Detection
Published on: January 26, 2024
1.0K
Circulating lncRNAs as biomarkers for severe dengue using a machine learning approach
Rodolfo Katz1, Nguyen Minh Nam2, Tulio de Lima Campos3
1Department of Clinical Microbiology and Immunology, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
The Journal of Infection
|March 16, 2025
Summary
This study identifies long non-coding RNAs (lncRNAs) as promising biomarkers for predicting severe dengue (SD). A new lncRNA panel accurately identifies high-risk patients, aiding early intervention and reducing healthcare burdens.
Area of Science:
- Molecular Biology
- Infectious Diseases
- Biomarker Discovery
Background:
- Dengue virus (DENV) infection poses a global health threat, with severe dengue (SD) causing significant mortality.
- Current methods for predicting SD progression lack specificity, straining healthcare systems in endemic areas.
- Circulating long non-coding RNAs (lncRNAs) show potential as stable and reliable biomarkers.
Purpose of the Study:
- To investigate the utility of lncRNAs as predictive markers for severe dengue (SD).
- To develop a predictive model for SD progression using lncRNAs.
- To assess the clinical applicability of lncRNA-based prediction in dengue patient management.
Main Methods:
- Differential gene expression analysis and quantitative PCR (qPCR) arrays were used to identify candidate lncRNAs.
- Plasma lncRNA levels were quantified in Vietnamese dengue patients (n=377) and healthy controls (n=128).
- Machine learning algorithms were employed to build a predictive model for SD risk.
Main Results:
- The developed lncRNA predictive model achieved high sensitivity and specificity (AUC = 0.98).
- The model accurately identified 17 out of 18 non-surviving patients as high-risk upon admission.
- This significantly outperformed traditional warning signs, which identified only 9 of these critical cases.
Conclusions:
- A panel of lncRNAs demonstrates significant potential for predicting severe dengue (SD).
- This biomarker approach could enhance early patient stratification and management in dengue-endemic regions.
- Implementing lncRNA-based prediction may alleviate healthcare system burdens and improve patient outcomes.

